• B Jovanović, V Bumbasirević, Z Terziski, M Pandurović, I Palibrk, V Djukić, A Karamarković, D Radenković, R Stevanović, and D Simić.
• Institut za Anesteziju i Reanimaciju, Urgentni centar, KCS, Beograd.
• Acta Chir Iugosl. 2007 Jan 1;54(1):71-5.

AbstractMassive hemorrhage is a formidable challenge for anesthesia care providers in the elective setting and poses even greater potential challenges in the trauma setting. In all this cases, the anesthesia care providers are faced with large-volume resuscitations that typically start with crystalloid and colloid and rapidly progress to blood and blood products. These large-volume replacement may cause coagulopathy, which can be difficult to manage in the setting of ongoing blood loss. Coagulopathy associated with massive transfusion is multifactorial event that results from hemodilution, hypothermia, the use of fractionated blood products and disseminated intravascular coagulation. Maintaining a normal body temperature is a first-line, effective strategy to improve hemostasis during massive transfusion. Treatment strategies include the maintenance of adequate tissue perfusion, the corection of anemia, and the use of hemostatic blood products.

13 keywords...

hide…